Purchase Order 75N91021P00574

The National Cancer Institute issued a purchase order to Life Technologies Corporation on September 15, 2020, for BDT kits used in Sanger DNA sequencing and genotyping, with a ceiling value of $17,416.80 and a firm fixed price. Work is performed at the vendor's facility in Grand Island, New York. The order is for consumable supplies that LTG scientific staff use to verify cloned construct sequences and genotype human DNA samples. The order is scheduled for completion by September 30, 2020.

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for BigDye Terminator V1.1 Cycle Sequencing Kit with a ceiling value of $41,430.40 on September 18, 2017, with ultimate completion on October 2, 2017. Work is performed in Bethesda, Maryland. This firm fixed price purchase order is for laboratory sequencing consumables supporting genetic analysis operations at the Institute.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $42,072.80 on February 5, 2018, for a Big Dye Terminator V1.1 Cycle Sequencing Kit. The order is firm fixed price with no small business set-aside. Place of performance is Carlsbad, California. The ultimate completion date is March 5, 2018.</p>

<p>The National Cancer Institute issued a delivery order to Life Technologies Corporation on January 13, 2020, with a ceiling value of $42,072.38 for BigDye Terminator V1.1 cycle sequencing kit and reagents and consumables for Applied Biosystems 3500XL and 3730XL genetic analyzers.</p> <p>Place of performance is Carlsbad, CA. The order is firm fixed price and completes April 30, 2020. Life Technologies is a subsidiary of Thermo Fisher Scientific Inc.</p>

The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,478.46 on June 24, 2019, for drugs and biologicals with a completion date of July 31, 2019. Work is performed in Grand Island, New York. This firm fixed-price order procures specialized biomedical research instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio—the vendor operates as a direct supplier of genetic analysis instruments, immunoassay systems, flow...

This is a $11,219.00 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency, to Life Technologies Corporation for the delivery of BIGDYE &amp; TRADE TERMINATOR V1.1 CYCLE SEQUENCING KIT. The award has no set-aside designation and is scheduled for completion by September 23, 2024. Life Technologies Corporation is a manufacturer of scientific instruments, reagents, and consumables that provides products and services to support federal initiatives related to...

The National Cancer Institute issued a delivery order to Life Technologies Corporation on June 6, 2019, with a ceiling value of $43,354.52 for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers. Place of performance is Grand Island, NY. The order is firm fixed price with an ultimate completion date of July 6, 2019. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific Inc. and specializes in biomedical research and genetic analysis...

<p>The National Cancer Institute issued a $32,582.74 delivery order to Life Technologies Corporation on September 17, 2018, for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers.</p> <p>Place of performance is Grand Island, NY. The order has a ceiling value of $32,582.74 with an ultimate completion date of September 24, 2018. Pricing is firm fixed price. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $12,187.66 on August 21, 2020, for genotyping experiments. Performance is at Life Technologies' facility in Grand Island, New York. The order carries a firm fixed price and has an ultimate completion date of October 30, 2020. No set-aside category applies.</p>

The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,478.46 on May 23, 2019, for drugs and biologicals with an ultimate completion date of June 23, 2019. Work is performed in Grand Island, New York. The order is firm fixed price with no small business set-aside. Life Technologies, a wholly owned subsidiary of Thermo Fisher Scientific, supplies specialized biomedical research instruments, reagents, and consumables to federal agencies as a prime...